BioHarvest Sciences (NASDAQ:BHST) Stock Price Up 3% – Should You Buy?

Shares of BioHarvest Sciences Inc. (NASDAQ:BHST) traded up 3% during trading on Tuesday . The stock traded as high as $6.12 and last traded at $6.12. 12,484 shares traded hands during mid-day trading, an increase of 63% from the average session volume of 7,662 shares. The stock had previously closed at $5.94.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on the stock. Maxim Group began coverage on shares of BioHarvest Sciences in a report on Wednesday, December 18th. They issued a “buy” rating and a $12.00 price target on the stock. HC Wainwright assumed coverage on shares of BioHarvest Sciences in a research report on Friday, December 6th. They issued a “buy” rating and a $14.00 price target for the company.

BioHarvest Sciences Stock Performance

The stock’s 50 day simple moving average is $5.58. The company has a market capitalization of $104.96 million, a price-to-earnings ratio of -5.12 and a beta of 2.27.

Institutional Investors Weigh In On BioHarvest Sciences

A hedge fund recently bought a new stake in BioHarvest Sciences stock. TD Waterhouse Canada Inc. acquired a new position in shares of BioHarvest Sciences Inc. (NASDAQ:BHST) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 12,042 shares of the company’s stock, valued at approximately $69,000. TD Waterhouse Canada Inc. owned about 0.07% of BioHarvest Sciences at the end of the most recent quarter.

BioHarvest Sciences Company Profile

BioHarvest Sciences Inc is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications.